Agios Pharmaceuticals Inc. (AGIO), a commercial-stage company pioneering therapies for rare diseases, is anticipated to release crucial clinical trial data by the end of this year, making it an event to keep an eye on.
The scheduled data presentation includes results from the phase IIa segment of a phase IIa/IIb multicenter, efficacy, and safety study of AG-946 in participants with anemia due to lower-risk myelodysplastic syndromes.
For comments and feedback contact: editorial@rttnews.com
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.